Latham Advises Investor Eurazeo On €985M Eye Care Biz Sale
European investment business Eurazeo SE confirmed Monday it intends to sell eye treatment products maker Dorc to medical technology company Zeiss in a deal valued at nearly €1 billion ($1.1 billion),...To view the full article, register now.
Already a subscriber? Click here to view full article